N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-bis((tert-butyldimethylsilyl)oxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 95%, 500mg

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 4000 ml, 250 mm, 1 Piece

2-Fluoro-5-methoxy-3-(trifluoromethyl)phenylboronic acid, 98%, 5g

5-(4-Fluorophenyl)isoxazole, 95.0%, 25g

(1R)-1-(5-FLUORO-2-IODOPHENYL)ETHAN-1-OL, 95%, 250mg

(4-Bromo-2-(trifluoromethyl)phenyl)methanol, 95.0%, 1g

6-Chloronicotinic acid, 99.00%, 1kg

4-BROMO-6-CHLORO-2-METHYLPYRIDAZIN-3(2H)-ONE, 95.0%, 5g

1-(TERT-BUTYL) 4-METHYL 3-BROMO-1H-INDOLE-1,4-DICARBOXYLATE, 95.0%, 5g

2,3-Dihydroimidazo[2,1-b][1,3]benzothiazol-6-amine, 95.0%, 5g

5-HEPTENOIC ACID, 7-[(1R,2R,3R,5S)-3,5-DIHYDROXY-2-[(1E,3R)-3-HYDROXY-4-[3-(TRIFLUOROMETHYL)PHENOXY]-1-BUTEN-1-YL]CYCLOPENTYL]-, 1-METHYLETHYL ESTER, (5Z)-, 98%, 100mg

2-Bromo-4-methoxyphenol, 97.0%, 100g

2-Amino-5-iodo-4-methylpyridine, 95.0%, 25g